标题
Mammalian target of rapamycin inhibitor-associated stomatitis
作者
关键词
-
出版物
Future Oncology
Volume 9, Issue 12, Pages 1883-1892
出版商
Future Medicine Ltd
发表日期
2013-12-03
DOI
10.2217/fon.13.141
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- NCCN Task Force Report: Optimizing Treatment of Advanced Renal Cell Carcinoma With Molecular Targeted Therapy
- (2017) Gary R. Hudes et al. Journal of the National Comprehensive Cancer Network
- A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients
- (2013) Fabiana Martins et al. ORAL ONCOLOGY
- Experiences with the FACT-EGFRI-18 instrument in EGFRI-associated mucocutaneous adverse events
- (2013) Christine B. Boers-Doets et al. SUPPORTIVE CARE IN CANCER
- New developments in management of oral mucositis in patients with head and neck cancer or receiving targeted anticancer therapies
- (2012) E. Li et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Viral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients
- (2012) M T van der Beek et al. BONE MARROW TRANSPLANTATION
- Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients
- (2012) Alexa M. G. A. Laheij et al. SUPPORTIVE CARE IN CANCER
- Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma
- (2011) Camillo Porta et al. EUROPEAN JOURNAL OF CANCER
- Ridaforolimus: a promising drug in the treatment of soft-tissue sarcoma and other malignancies
- (2011) Janet E Dancey et al. Future Oncology
- Vanderbilt head and neck symptom survey version 2.0: Report of the development and initial testing of a subscale for assessment of oral health
- (2011) Emily Cooperstein et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
- (2011) Seth A. Wander et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas
- (2011) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review
- (2011) C. B. Boers-Doets et al. ONCOLOGIST
- Clinical presentation and management of mTOR inhibitor-associated stomatitis
- (2011) Marcio Augusto de Oliveira et al. ORAL ONCOLOGY
- Oral complications of targeted cancer therapies: A narrative literature review
- (2011) A.L. Watters et al. ORAL ONCOLOGY
- Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives
- (2011) Marc Dufour et al. Cancers
- mTOR inhibitor-associated dermatologic and mucosal problems
- (2010) Josep M. Campistol et al. CLINICAL TRANSPLANTATION
- Aphthous ulcers
- (2010) Diana V. Messadi et al. Dermatologic Therapy
- Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approach
- (2010) Ronald M Bukowski EXPERT OPINION ON PHARMACOTHERAPY
- Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis
- (2010) Natalia Lewkowicz et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma
- (2010) V. E. Kwitkowski et al. ONCOLOGIST
- A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea
- (2010) Sharon Elad et al. SUPPORTIVE CARE IN CANCER
- A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact
- (2010) S. B. Jensen et al. SUPPORTIVE CARE IN CANCER
- The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity
- (2009) M. D. Säemann et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel
- (2009) C. Sessa et al. ANNALS OF ONCOLOGY
- Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib
- (2009) W.J. Lee et al. BRITISH JOURNAL OF DERMATOLOGY
- Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity
- (2009) Nielka P. van Erp et al. JOURNAL OF CLINICAL ONCOLOGY
- The multiple facets of mTOR in immunity
- (2009) Thomas Weichhart et al. TRENDS IN IMMUNOLOGY
- Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features
- (2008) J. Bellmunt et al. ANNALS OF ONCOLOGY
- Targeted Therapies for Metastatic Renal Cell Carcinoma: An Overview of Toxicity and Dosing Strategies
- (2008) T. E. Hutson et al. ONCOLOGIST
- Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma
- (2007) Naeem Bhojani et al. EUROPEAN UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started